Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Alberto Pinsino
  • Francesco Castagna
  • Amelia M. Zuver
  • Eugene A. Royzman
  • Mojdeh Nasiri
  • Eric J. Stöhr
  • Barbara Cagliostro
  • Barry McDonnell
  • John R. Cockcroft
  • A. Reshad Garan
  • Veli K. Topkara
  • P. Christian Schulze
  • Koji Takeda
  • Hiroo Takayama
  • Yoshifumi Naka
  • Ryan T. Demmer
  • Joshua Z. Willey
  • Melana Yuzefpolskaya
  • Paolo C. Colombo

External Research Organisations

  • Columbia University
  • Bridgeport Hospital
  • Cardiff Metropolitan University
  • Friedrich Schiller University Jena
  • University of Minnesota
View graph of relations

Details

Original languageEnglish
Pages (from-to)396-405
Number of pages10
JournalJournal of Heart and Lung Transplantation
Volume38
Issue number4
Early online date15 Nov 2018
Publication statusPublished - Apr 2019
Externally publishedYes

Abstract

BACKGROUND: Elevated blood pressure (BP) has been linked to adverse events during left ventricular assist device support. In this study we investigated the association between outpatient BP and stroke or suspected pump thrombosis among HeartMate II (HMII) recipients. METHODS: We retrospectively studied 220 HMII patients. Serial outpatient BP measurements were averaged. Patients were categorized by: (1) mean arterial pressure (MAP), high (>90 mm Hg) vs intermediate (80 mm Hg ≤ MAP ≤ 90 mm Hg) vs low (<80 mm Hg); (2) systolic BP (SBP), high (≥101 mm Hg, median) vs low; and (3) pulse pressure (PP), high (≥22 mm Hg, median) vs low. To assess visit-to-visit BP variability, patients were divided in quartiles of standard deviation of MAP and SBP. The primary end-point was the composite of stroke or suspected pump thrombosis. RESULTS: The risk for the primary end-point was increased in the high MAP group (adjusted hazard ratio [HR] 2.75, 95% confidence interval [CI] 1.49 to 5.05, vs intermediate MAP; and 6.73, 1.9 to 23.9, vs low MAP). MAP had higher predictive value for the primary end-point compared with SBP (p = 0.05). Patients with high SBP had a higher rate of stroke (HR 2.8, 95% CI 1.09 to 7.17, vs low SBP). The combination of high SBP and low PP was associated with the highest risk for stroke. The lowest quartile of visit-to-visit MAP variability was associated with the highest risk for the primary end-point. CONCLUSIONS: Elevated outpatient BP is associated with increased risk for stroke or suspected pump thrombosis in HMII recipients. Reduced PP and low visit-to-visit BP variability may confer additional risk.

Keywords

    Blood Pressure, LVAD, MCS, Pulsatility, Pump Thrombosis, Stroke

ASJC Scopus subject areas

Cite this

Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device. / Pinsino, Alberto; Castagna, Francesco; Zuver, Amelia M. et al.
In: Journal of Heart and Lung Transplantation, Vol. 38, No. 4, 04.2019, p. 396-405.

Research output: Contribution to journalArticleResearchpeer review

Pinsino, A, Castagna, F, Zuver, AM, Royzman, EA, Nasiri, M, Stöhr, EJ, Cagliostro, B, McDonnell, B, Cockcroft, JR, Garan, AR, Topkara, VK, Schulze, PC, Takeda, K, Takayama, H, Naka, Y, Demmer, RT, Willey, JZ, Yuzefpolskaya, M & Colombo, PC 2019, 'Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device', Journal of Heart and Lung Transplantation, vol. 38, no. 4, pp. 396-405. https://doi.org/10.1016/j.healun.2018.11.003
Pinsino, A., Castagna, F., Zuver, A. M., Royzman, E. A., Nasiri, M., Stöhr, E. J., Cagliostro, B., McDonnell, B., Cockcroft, J. R., Garan, A. R., Topkara, V. K., Schulze, P. C., Takeda, K., Takayama, H., Naka, Y., Demmer, R. T., Willey, J. Z., Yuzefpolskaya, M., & Colombo, P. C. (2019). Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device. Journal of Heart and Lung Transplantation, 38(4), 396-405. https://doi.org/10.1016/j.healun.2018.11.003
Pinsino A, Castagna F, Zuver AM, Royzman EA, Nasiri M, Stöhr EJ et al. Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device. Journal of Heart and Lung Transplantation. 2019 Apr;38(4):396-405. Epub 2018 Nov 15. doi: 10.1016/j.healun.2018.11.003
Download
@article{fac8df8580914b8ea0cece99877b3f10,
title = "Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device",
abstract = "BACKGROUND: Elevated blood pressure (BP) has been linked to adverse events during left ventricular assist device support. In this study we investigated the association between outpatient BP and stroke or suspected pump thrombosis among HeartMate II (HMII) recipients. METHODS: We retrospectively studied 220 HMII patients. Serial outpatient BP measurements were averaged. Patients were categorized by: (1) mean arterial pressure (MAP), high (>90 mm Hg) vs intermediate (80 mm Hg ≤ MAP ≤ 90 mm Hg) vs low (<80 mm Hg); (2) systolic BP (SBP), high (≥101 mm Hg, median) vs low; and (3) pulse pressure (PP), high (≥22 mm Hg, median) vs low. To assess visit-to-visit BP variability, patients were divided in quartiles of standard deviation of MAP and SBP. The primary end-point was the composite of stroke or suspected pump thrombosis. RESULTS: The risk for the primary end-point was increased in the high MAP group (adjusted hazard ratio [HR] 2.75, 95% confidence interval [CI] 1.49 to 5.05, vs intermediate MAP; and 6.73, 1.9 to 23.9, vs low MAP). MAP had higher predictive value for the primary end-point compared with SBP (p = 0.05). Patients with high SBP had a higher rate of stroke (HR 2.8, 95% CI 1.09 to 7.17, vs low SBP). The combination of high SBP and low PP was associated with the highest risk for stroke. The lowest quartile of visit-to-visit MAP variability was associated with the highest risk for the primary end-point. CONCLUSIONS: Elevated outpatient BP is associated with increased risk for stroke or suspected pump thrombosis in HMII recipients. Reduced PP and low visit-to-visit BP variability may confer additional risk.",
keywords = "Blood Pressure, LVAD, MCS, Pulsatility, Pump Thrombosis, Stroke",
author = "Alberto Pinsino and Francesco Castagna and Zuver, {Amelia M.} and Royzman, {Eugene A.} and Mojdeh Nasiri and St{\"o}hr, {Eric J.} and Barbara Cagliostro and Barry McDonnell and Cockcroft, {John R.} and Garan, {A. Reshad} and Topkara, {Veli K.} and Schulze, {P. Christian} and Koji Takeda and Hiroo Takayama and Yoshifumi Naka and Demmer, {Ryan T.} and Willey, {Joshua Z.} and Melana Yuzefpolskaya and Colombo, {Paolo C.}",
note = "Funding Information: P.C.C. is recipient of a research grant from Abbott; he also serves as a consultant (with no honoraria) for the same company. Y.N. serves as a consultant for Abbott. The remaining authors have no conflicts of interest to disclose. This research has been supported by funds from the Lisa and Mark Schwartz Program to Reverse Heart Failure at New York‒Presbyterian Hospital/Columbia University. ",
year = "2019",
month = apr,
doi = "10.1016/j.healun.2018.11.003",
language = "English",
volume = "38",
pages = "396--405",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "4",

}

Download

TY - JOUR

T1 - Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device

AU - Pinsino, Alberto

AU - Castagna, Francesco

AU - Zuver, Amelia M.

AU - Royzman, Eugene A.

AU - Nasiri, Mojdeh

AU - Stöhr, Eric J.

AU - Cagliostro, Barbara

AU - McDonnell, Barry

AU - Cockcroft, John R.

AU - Garan, A. Reshad

AU - Topkara, Veli K.

AU - Schulze, P. Christian

AU - Takeda, Koji

AU - Takayama, Hiroo

AU - Naka, Yoshifumi

AU - Demmer, Ryan T.

AU - Willey, Joshua Z.

AU - Yuzefpolskaya, Melana

AU - Colombo, Paolo C.

N1 - Funding Information: P.C.C. is recipient of a research grant from Abbott; he also serves as a consultant (with no honoraria) for the same company. Y.N. serves as a consultant for Abbott. The remaining authors have no conflicts of interest to disclose. This research has been supported by funds from the Lisa and Mark Schwartz Program to Reverse Heart Failure at New York‒Presbyterian Hospital/Columbia University.

PY - 2019/4

Y1 - 2019/4

N2 - BACKGROUND: Elevated blood pressure (BP) has been linked to adverse events during left ventricular assist device support. In this study we investigated the association between outpatient BP and stroke or suspected pump thrombosis among HeartMate II (HMII) recipients. METHODS: We retrospectively studied 220 HMII patients. Serial outpatient BP measurements were averaged. Patients were categorized by: (1) mean arterial pressure (MAP), high (>90 mm Hg) vs intermediate (80 mm Hg ≤ MAP ≤ 90 mm Hg) vs low (<80 mm Hg); (2) systolic BP (SBP), high (≥101 mm Hg, median) vs low; and (3) pulse pressure (PP), high (≥22 mm Hg, median) vs low. To assess visit-to-visit BP variability, patients were divided in quartiles of standard deviation of MAP and SBP. The primary end-point was the composite of stroke or suspected pump thrombosis. RESULTS: The risk for the primary end-point was increased in the high MAP group (adjusted hazard ratio [HR] 2.75, 95% confidence interval [CI] 1.49 to 5.05, vs intermediate MAP; and 6.73, 1.9 to 23.9, vs low MAP). MAP had higher predictive value for the primary end-point compared with SBP (p = 0.05). Patients with high SBP had a higher rate of stroke (HR 2.8, 95% CI 1.09 to 7.17, vs low SBP). The combination of high SBP and low PP was associated with the highest risk for stroke. The lowest quartile of visit-to-visit MAP variability was associated with the highest risk for the primary end-point. CONCLUSIONS: Elevated outpatient BP is associated with increased risk for stroke or suspected pump thrombosis in HMII recipients. Reduced PP and low visit-to-visit BP variability may confer additional risk.

AB - BACKGROUND: Elevated blood pressure (BP) has been linked to adverse events during left ventricular assist device support. In this study we investigated the association between outpatient BP and stroke or suspected pump thrombosis among HeartMate II (HMII) recipients. METHODS: We retrospectively studied 220 HMII patients. Serial outpatient BP measurements were averaged. Patients were categorized by: (1) mean arterial pressure (MAP), high (>90 mm Hg) vs intermediate (80 mm Hg ≤ MAP ≤ 90 mm Hg) vs low (<80 mm Hg); (2) systolic BP (SBP), high (≥101 mm Hg, median) vs low; and (3) pulse pressure (PP), high (≥22 mm Hg, median) vs low. To assess visit-to-visit BP variability, patients were divided in quartiles of standard deviation of MAP and SBP. The primary end-point was the composite of stroke or suspected pump thrombosis. RESULTS: The risk for the primary end-point was increased in the high MAP group (adjusted hazard ratio [HR] 2.75, 95% confidence interval [CI] 1.49 to 5.05, vs intermediate MAP; and 6.73, 1.9 to 23.9, vs low MAP). MAP had higher predictive value for the primary end-point compared with SBP (p = 0.05). Patients with high SBP had a higher rate of stroke (HR 2.8, 95% CI 1.09 to 7.17, vs low SBP). The combination of high SBP and low PP was associated with the highest risk for stroke. The lowest quartile of visit-to-visit MAP variability was associated with the highest risk for the primary end-point. CONCLUSIONS: Elevated outpatient BP is associated with increased risk for stroke or suspected pump thrombosis in HMII recipients. Reduced PP and low visit-to-visit BP variability may confer additional risk.

KW - Blood Pressure

KW - LVAD

KW - MCS

KW - Pulsatility

KW - Pump Thrombosis

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85058385308&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2018.11.003

DO - 10.1016/j.healun.2018.11.003

M3 - Article

C2 - 30559034

AN - SCOPUS:85058385308

VL - 38

SP - 396

EP - 405

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 4

ER -

By the same author(s)